(1) You are in a room with your peers from the other
companies in our coverage universe. The audience will invest in only
one company. Give me two or three reasons why it should be your
company.
(2) What is the most important strategic decision
you’ve made in the last year
(3) What was your most disappointing setback in the
last year?
(4) Does any member of the executive team currently
have a hedge, collar, or similar position on his/her stock or stock
options? If no, is this prohibited? Have you backdated any options
grants?
(5) Manufacturing is often a major stumbling block
for young companies. How will your company avoid this going forward?
What unique risks are posed by your particular manufacturing strategy?
(6) If you look across the entire biotechnology
field, what science or technology do you think will make the biggest
impact over the next two years?
(7) Looking again across the entire biotech field,
what structural (regulatory, marketing, etc.) changes do you see as
important over the next two years?
